|
2025-04-10 |
2025-04-09 |
V
Vente
|
Garrison Michael David
EVP & President, Medical
Dirigeant
|
1 000
-8.9%
197,28
94 497 USD
|
1 000
-8.9%
|
197,28
|
100 000 USD
|
|
|
2025-03-19 |
2025-03-18 |
V
Vente
|
Byrd Richard
EVP & President Interventional
Dirigeant
|
459
-6.2%
230,00
105 570 USD
|
459
-6.2%
|
230,00
|
105 570 USD
|
|
|
2025-03-13 |
2025-03-12 |
V
Vente
|
Byrd Richard
EVP & President Interventional
Dirigeant
|
1 940
-20.7%
224,91
436 325 USD
|
1 940
-20.7%
|
224,91
|
436 325 USD
|
|
|
2025-02-12 |
2025-02-12 |
V
Vente
|
SCOTT BERTRAM L
Administrateur non-exécutif
|
700
-1.9%
227,99
159 593 USD
|
700
-1.9%
|
227,99
|
159 593 USD
|
|
|
2025-02-10 |
2025-02-10 |
A
Achat
|
Henderson Jeffrey William
Administrateur non-exécutif
|
1 500
+23.0%
233,62
350 430 USD
|
1 500
+23.0%
|
233,62
|
350 430 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Neal Shana Carol
EVP and Chief People Officer
Dirigeant
|
787
-4.9%
240,00
188 880 USD
|
787
-4.9%
|
240,00
|
188 880 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Shan David
EVP and Chief ISC Officer
Dirigeant
|
500
-8.0%
240,00
120 000 USD
|
500
-8.0%
|
240,00
|
120 000 USD
|
|
|
2025-01-21 |
2025-01-17 |
V
Vente
|
Garrison Michael David
EVP & President, Medical
Dirigeant
|
597
-9.7%
236,51
141 196 USD
|
597
-9.7%
|
236,51
|
141 196 USD
|
|
|
2025-01-10 |
2025-01-07 |
V
Vente
|
Neal Shana Carol
EVP and Chief People Officer
Dirigeant
|
788
-4.6%
235,00
185 180 USD
|
788
-4.6%
|
235,00
|
185 180 USD
|
|
|
2024-12-20 |
2024-12-19 |
V
Vente
|
Garrison Michael David
EVP & President, Medical
Dirigeant
|
2 838
-31.6%
223,33
633 811 USD
|
2 838
-31.6%
|
223,33
|
633 811 USD
|
|
|
2024-12-10 |
2024-12-09 |
V
Vente
|
Goette Roland
EVP and President, EMEA
Dirigeant
|
638
-4.3%
219,03
139 741 USD
|
638
-4.3%
|
219,03
|
139 741 USD
|
|
|
2024-12-10 |
2024-12-06 |
V
Vente
|
Goette Roland
EVP and President, EMEA
Dirigeant
|
4 483
-15.6%
221,01
990 788 USD
|
4 483
-15.6%
|
221,01
|
990 788 USD
|
|
|
2024-12-10 |
2024-12-06 |
V
Vente
|
Neal Shana Carol
EVP and Chief People Officer
Dirigeant
|
1 000
-5.6%
220,49
220 490 USD
|
1 000
-5.6%
|
220,49
|
220 490 USD
|
|
|
2024-12-06 |
2024-12-05 |
V
Vente
|
Shan David
EVP and Chief ISC Officer
Dirigeant
|
1 500
-19.3%
220,25
330 375 USD
|
1 500
-19.3%
|
220,25
|
330 375 USD
|
|
|
2024-06-11 |
2024-06-10 |
V
Vente
|
Spoerel Thomas J
SVP,Controller&Chief Acct Off
Dirigeant
|
300
-13.2%
239,31
71 793 USD
|
300
-13.2%
|
239,31
|
71 793 USD
|
|
|
2024-05-16 |
2024-05-15 |
V
Vente
|
Goette Roland
EVP and President EMEA
Dirigeant
|
1 100
-8.9%
237,46
261 206 USD
|
1 100
-8.9%
|
237,46
|
261 206 USD
|
|
|
2024-05-16 |
2024-05-15 |
V
Vente
|
Goette Roland
EVP and President EMEA
Dirigeant
|
1 400
-10.1%
236,99
331 786 USD
|
1 400
-10.1%
|
236,99
|
331 786 USD
|
|
|
2024-05-16 |
2024-05-15 |
V
Vente
|
Goette Roland
EVP and President EMEA
Dirigeant
|
800
-5.5%
235,29
188 232 USD
|
800
-5.5%
|
235,29
|
188 232 USD
|
|
|
2024-05-15 |
2024-05-13 |
V
Vente
|
Goette Roland
EVP and President EMEA
Dirigeant
|
28
-0.2%
237,90
6 661 USD
|
28
-0.2%
|
237,90
|
6 661 USD
|
|
|
2024-05-15 |
2024-05-13 |
V
Vente
|
Goette Roland
EVP and President EMEA
Dirigeant
|
1 572
-9.7%
237,14
372 784 USD
|
1 572
-9.7%
|
237,14
|
372 784 USD
|
|
|
2024-05-15 |
2024-05-13 |
V
Vente
|
Goette Roland
EVP and President EMEA
Dirigeant
|
1 700
-9.5%
236,28
401 676 USD
|
1 700
-9.5%
|
236,28
|
401 676 USD
|
|
|
2024-05-01 |
2024-04-30 |
V
Vente
|
Garrison Michael David
EVP & President Medical
Dirigeant
|
1 715
-24.2%
232,81
399 269 USD
|
1 715
-24.2%
|
232,81
|
399 269 USD
|
|
|
2024-03-15 |
2024-03-14 |
V
Vente
|
Spoerel Thomas J
SVP,Controller&Chief Acct Off
Dirigeant
|
282
-11.0%
238,29
67 198 USD
|
282
-11.0%
|
238,29
|
67 198 USD
|
|
|
2023-12-12 |
2023-12-11 |
V
Vente
|
Garrison Michael David
EVP & President Medical
Dirigeant
|
1 239
-14.6%
232,46
288 018 USD
|
1 239
-14.6%
|
232,46
|
288 018 USD
|
|
|
2023-11-29 |
2023-11-28 |
V
Vente
|
Byrd Richard
EVP & President Interventional
Dirigeant
|
2 156
-34.4%
238,47
514 141 USD
|
2 156
-34.4%
|
238,47
|
514 141 USD
|
|
|
2023-09-06 |
2023-09-05 |
V
Vente
|
Byrd Richard
EVP & President Interventional
Dirigeant
|
459
-11.8%
274,48
125 986 USD
|
459
-11.8%
|
274,48
|
125 986 USD
|
|
|
2023-08-30 |
2023-08-28 |
V
Vente
|
Fraser Claire
Administrateur non-exécutif
|
848
-3.8%
281,66
238 848 USD
|
848
-3.8%
|
281,66
|
238 848 USD
|
|
|
2023-08-14 |
2023-08-11 |
V
Vente
|
Hickey David
EVP & President, Life Sciences
Dirigeant
|
2 974
-41.5%
277,85
826 326 USD
|
2 974
-41.5%
|
277,85
|
826 326 USD
|
|
|
2023-08-09 |
2023-08-08 |
V
Vente
|
Garrison Michael David
EVP & President Medical
Dirigeant
|
1 300
-20.1%
277,13
360 269 USD
|
1 300
-20.1%
|
277,13
|
360 269 USD
|
|
|
2023-02-06 |
2023-02-03 |
VP
Vente planifiée
|
Byrd Richard
EVP & President Interventional
Dirigeant
|
1 421
-25.6%
248,60
353 261 USD
|
1 421
-25.6%
|
248,60
|
353 261 USD
|
|
|
2022-08-17 |
2022-08-15 |
VP
Vente planifiée
|
Polen Thomas E Jr
Chairman, CEO and President
Administrateur exécutif
|
9 500
-24.8%
265,13
2 518 735 USD
|
9 500
-24.8%
|
265,13
|
2 518 735 USD
|
|
|
2022-08-17 |
2022-08-15 |
VP
Vente planifiée
|
Hickey David
EVP & President, Life Sciences
Dirigeant
|
475
-12.5%
265,00
125 875 USD
|
475
-12.5%
|
265,00
|
125 875 USD
|
|
|
2022-08-11 |
2022-08-09 |
VP
Vente planifiée
|
Khichi Samrat S.
EVP and General Counsel
Dirigeant
|
9 185
-60.8%
260,44
2 392 141 USD
|
9 185
-60.8%
|
260,44
|
2 392 141 USD
|
|
|
2022-08-11 |
2022-08-09 |
VP
Vente planifiée
|
Polen Thomas E Jr
Executive Vice President
Dirigeant
|
1 652
-5.4%
260,00
429 520 USD
|
1 652
-5.4%
|
260,00
|
429 520 USD
|
|
|
2022-08-11 |
2022-08-08 |
VP
Vente planifiée
|
Khichi Samrat S.
EVP and General Counsel
Dirigeant
|
7 295
-55.2%
260,44
1 899 910 USD
|
7 295
-55.2%
|
260,44
|
1 899 910 USD
|
|
|
2022-06-09 |
2022-06-07 |
V
Vente
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Dirigeant
|
443
-29.5%
260,00
115 180 USD
|
443
-29.5%
|
260,00
|
115 180 USD
|
|
|
2022-05-10 |
2022-05-06 |
V
Vente
|
Hickey David
EVP & President, Life Sciences
Dirigeant
|
475
-11.1%
256,00
121 600 USD
|
475
-11.1%
|
256,00
|
121 600 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
601
-9.3%
271,90
163 412 USD
|
601
-9.3%
|
271,90
|
163 412 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
203
-3.3%
271,90
55 196 USD
|
203
-3.3%
|
271,90
|
55 196 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
284
-4.6%
271,90
77 220 USD
|
284
-4.6%
|
271,90
|
77 220 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
744
-11.2%
271,90
202 294 USD
|
744
-11.2%
|
271,90
|
202 294 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
2 036
-25.7%
271,90
553 588 USD
|
2 036
-25.7%
|
271,90
|
553 588 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
4 442
-43.1%
271,90
1 207 780 USD
|
4 442
-43.1%
|
271,90
|
1 207 780 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
3 914
-40.0%
271,90
1 064 217 USD
|
3 914
-40.0%
|
271,90
|
1 064 217 USD
|
|
|
2022-02-28 |
2022-02-25 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
2 150
-26.8%
271,90
584 585 USD
|
2 150
-26.8%
|
271,90
|
584 585 USD
|
|
|
2022-02-10 |
2022-02-08 |
V
Vente
|
Fraser Claire
Administrateur non-exécutif
|
841
-3.8%
271,70
228 500 USD
|
841
-3.8%
|
271,70
|
228 500 USD
|
|
|
2022-02-07 |
2022-02-03 |
VP
Vente planifiée
|
Conroy Alexandre
EVP of Integrated Supply Chain
Dirigeant
|
6 410
-23.2%
270,16
1 731 726 USD
|
6 410
-23.2%
|
270,16
|
1 731 726 USD
|
|
|
2021-12-17 |
2021-12-16 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
2 789
-32.2%
255,00
711 195 USD
|
2 789
-32.2%
|
255,00
|
711 195 USD
|
|
|
2021-12-17 |
2021-12-16 |
V
Vente
|
Larson Betty D
EVP HR & CHRO
Dirigeant
|
552
-6.0%
255,00
140 760 USD
|
552
-6.0%
|
255,00
|
140 760 USD
|
|
|
2021-12-09 |
2021-12-07 |
V
Vente
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Dirigeant
|
233
-17.8%
250,00
58 250 USD
|
233
-17.8%
|
250,00
|
58 250 USD
|
|
|
2021-08-09 |
2021-08-06 |
V
Vente
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Dirigeant
|
266
-17.2%
242,30
64 452 USD
|
266
-17.2%
|
242,30
|
64 452 USD
|
|
|
2021-06-02 |
2021-05-28 |
V
Vente
|
Lim James C
Executive Vice President
Dirigeant
|
3 429
-81.1%
241,68
828 721 USD
|
3 429
-81.1%
|
241,68
|
828 721 USD
|
|
|
2021-05-28 |
2021-05-27 |
V
Vente
|
Fraser Claire
Administrateur non-exécutif
|
390
-1.9%
241,36
94 130 USD
|
390
-1.9%
|
241,36
|
94 130 USD
|
|
|
2020-11-24 |
2020-11-23 |
V
Vente
|
Goette Roland
EVP and President, EMEA
Dirigeant
|
930
-10.4%
230,10
213 993 USD
|
930
-10.4%
|
230,10
|
213 993 USD
|
|
|
2020-07-13 |
2020-07-09 |
VP
Vente planifiée
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Dirigeant
|
1 272
-11.0%
260,00
330 720 USD
|
1 272
-11.0%
|
260,00
|
330 720 USD
|
|
|
2020-06-05 |
2020-06-05 |
VP
Vente planifiée
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Dirigeant
|
1 049
-8.3%
243,20
255 117 USD
|
1 049
-8.3%
|
243,20
|
255 117 USD
|
|
|
2020-06-02 |
2020-06-02 |
VP
Vente planifiée
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Dirigeant
|
222
-1.5%
244,83
54 352 USD
|
222
-1.5%
|
244,83
|
54 352 USD
|
|
|
2020-05-08 |
2020-05-08 |
V
Vente
|
Fraser Claire
Administrateur non-exécutif
|
771
-3.7%
256,56
197 808 USD
|
771
-3.7%
|
256,56
|
197 808 USD
|
|
|
2020-03-17 |
2020-03-16 |
VP
Vente planifiée
|
Khichi Samrat S.
EVP and General Counsel
Dirigeant
|
4 349
-45.3%
224,53
976 481 USD
|
4 349
-45.3%
|
224,53
|
976 481 USD
|
|
|
2020-02-11 |
2020-02-11 |
V
Vente
|
Fraser Claire
Administrateur non-exécutif
|
700
-3.2%
258,70
181 090 USD
|
700
-3.2%
|
258,70
|
181 090 USD
|
|
|
2020-02-11 |
2020-02-11 |
V
Vente
|
Fraser Claire
Administrateur non-exécutif
|
800
-3.6%
258,73
206 984 USD
|
800
-3.6%
|
258,73
|
206 984 USD
|
|
|
2020-02-05 |
2020-02-04 |
VP
Vente planifiée
|
Campion Simon D
EVP and Segment President
Dirigeant
|
1 439
-11.8%
285,09
410 245 USD
|
1 439
-11.8%
|
285,09
|
410 245 USD
|
|
|
2020-02-05 |
2020-02-04 |
VP
Vente planifiée
|
Campion Simon D
EVP and Segment President
Dirigeant
|
2 744
-20.3%
285,09
782 287 USD
|
2 744
-20.3%
|
285,09
|
782 287 USD
|
|
|
2020-02-05 |
2020-02-04 |
VP
Vente planifiée
|
Campion Simon D
EVP and Segment President
Dirigeant
|
1 896
-15.0%
285,09
540 531 USD
|
1 896
-15.0%
|
285,09
|
540 531 USD
|
|
|
2020-02-05 |
2020-02-04 |
VP
Vente planifiée
|
Campion Simon D
EVP and Segment President
Dirigeant
|
1 600
-12.9%
285,09
456 144 USD
|
1 600
-12.9%
|
285,09
|
456 144 USD
|
|
|
2020-02-05 |
2020-02-04 |
VP
Vente planifiée
|
Campion Simon D
EVP and Segment President
Dirigeant
|
406
-3.6%
285,09
115 747 USD
|
406
-3.6%
|
285,09
|
115 747 USD
|
|
|
2020-02-05 |
2020-02-04 |
V
Vente
|
Mas Ribo Alberto
EVP and Pres, Life Sciences
Dirigeant
|
1 430
-14.6%
285,00
407 550 USD
|
1 430
-14.6%
|
285,00
|
407 550 USD
|
|
|
2020-01-28 |
2020-01-28 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
28 514
-12.0%
280,96
8 011 293 USD
|
28 514
-12.0%
|
280,96
|
8 011 293 USD
|
|
|
2020-01-27 |
2020-01-27 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
25 546
-10.9%
280,09
7 155 179 USD
|
25 546
-10.9%
|
280,09
|
7 155 179 USD
|
|
|
2020-01-27 |
2020-01-24 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
7 177
-3.3%
280,13
2 010 493 USD
|
7 177
-3.3%
|
280,13
|
2 010 493 USD
|
|
|
2020-01-27 |
2020-01-23 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
6 284
-2.9%
280,06
1 759 897 USD
|
6 284
-2.9%
|
280,06
|
1 759 897 USD
|
|
|
2020-01-10 |
2020-01-10 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
19 675
-8.6%
275,15
5 413 576 USD
|
19 675
-8.6%
|
275,15
|
5 413 576 USD
|
|
|
2020-01-10 |
2020-01-08 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
13 860
-6.2%
275,19
3 814 133 USD
|
13 860
-6.2%
|
275,19
|
3 814 133 USD
|
|
|
2020-01-03 |
2020-01-02 |
VP
Vente planifiée
|
FORLENZA VINCENT A
Chairman, CEO and President
Administrateur exécutif
|
33 365
-13.8%
271,28
9 051 257 USD
|
33 365
-13.8%
|
271,28
|
9 051 257 USD
|
|
|
2019-12-18 |
2019-12-16 |
VP
Vente planifiée
|
Mas Ribo Alberto
EVP and Pres, Life Sciences
Dirigeant
|
11 860
-54.7%
269,51
3 196 389 USD
|
11 860
-54.7%
|
269,51
|
3 196 389 USD
|
|
